DOUBLE BOND PHARMACEUTICALS AB has a total of 15 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals are LI FUCHAO, TECHNO GUARD CO LTD and ZHEN WEI.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lokot Igor | 12 |
#2 | Trukhachova Tatsiana | 2 |
#3 | Beliaev Sergey | 2 |
#4 | Atrakhimovich Natalia | 2 |
#5 | Bychkouski Pavel | 2 |
#6 | Igor Lokot | 1 |
#7 | Valiantsina Alinouskaya | 1 |
#8 | Yurkshtovich Tatjana | 1 |
#9 | Halouchyk Iryna | 1 |
#10 | Yurkshtovich Tatiana | 1 |
Publication | Filing date | Title |
---|---|---|
CN107334766A | The antineoplastic pharmaceutical compositions of stabilization comprising Temozolomide, and the preparation method of said composition | |
CN109069423A | Lung's targeted delivery of hydrophilic medicament | |
EA033526B1 | Targeted delivery of hydrophilic drugs |